rethinkTHC Search
Menu
Study breakdown

CBD Enhanced the Seizure-Fighting Effects of Phenobarbital in Newborn Rats

Animal StudyPreliminary evidence
The takeaway

In neonatal rats, CBD at moderate to high doses significantly enhanced the antiseizure effects of a sub-effective dose of phenobarbital, suggesting potential as an adjunct therapy for newborn seizures.

Neonatologists treating seizures, pediatric neurologists, epilepsy pharmacology researchers

CBD enhanced sub-effective phenobarbital doses to achieve significant seizure control

What the researchers found

Low CBD doses (3 and 30 mg/kg) had limited antiseizure effects alone, while higher doses (100 and 200 mg/kg) modestly reduced seizures. However, CBD at 30, 100, or 200 mg/kg significantly enhanced the efficacy of a sub-effective dose of phenobarbital (10 mg/kg), demonstrating dose-dependent potentiation. This synergistic effect could allow lower phenobarbital doses, reducing side effects.

Why it matters

Neonatal seizures are common and difficult to treat, with many newborns showing resistance to phenobarbital, the first-line treatment. CBD's ability to enhance phenobarbital's effects could allow effective seizure control at lower drug doses, potentially reducing the neurotoxic side effects associated with high-dose phenobarbital in developing brains.

The numbers in context

CBD doses: 3, 30, 100, 200 mg/kg. PB doses: 3, 10, 30, 50, 75 mg/kg. PTZ: 100 mg/kg. CBD 30-200 mg/kg + PB 10 mg/kg: significant seizure reduction. CBD alone: modest effects only at 100-200 mg/kg. PB 10 mg/kg alone: sub-effective. P10 Wistar rats.

How the study worked

Neonatal seizure model using 10-day-old Wistar rats. Rats were pretreated with phenobarbital (3-75 mg/kg) and/or CBD (3-200 mg/kg), then seizures were induced with subcutaneous PTZ (100 mg/kg). Seizure latency, duration, and severity were assessed.

What this study cannot tell us

Animal model in 10-day-old rats, which may not directly translate to human neonatal seizures. Single seizure induction method (PTZ). Acute dosing only. High CBD doses used may not be achievable in neonates. No pharmacokinetic data on CBD-PB interaction in neonates.

How to read the evidence

Preliminary evidence from an animal model using acute dosing in neonatal rats.

When this study was published

2025 preclinical study examining CBD-phenobarbital interaction in a neonatal seizure model.

The bigger picture

The combination of CBD with existing antiseizure medications is an active area of clinical interest. This preclinical study provides a rationale for testing CBD as an adjunct to phenobarbital specifically in neonatal seizures, where treatment options are limited and the developing brain is particularly vulnerable to medication side effects.

Questions still open

  • What is the mechanism of CBD-phenobarbital synergy? Would this potentiation occur in human neonates? Could CBD allow significant phenobarbital dose reductions in clinical practice? What are the safety implications of CBD-PB combination in developing brains?

Common questions

Can CBD be combined with phenobarbital for seizures?
In this neonatal rat study, CBD significantly enhanced the antiseizure effects of phenobarbital, even at a dose of phenobarbital that was ineffective alone. This potentiation effect suggests CBD could serve as an adjunct therapy, potentially allowing lower doses of phenobarbital.
Why is this important for newborns?
Phenobarbital is the primary seizure medication for newborns, but many babies are resistant to it, and high doses can cause neurotoxic side effects in developing brains. If CBD can enhance phenobarbital's effects, it could improve seizure control while reducing the dose-related risks.

Read the original research

Cannabidiol potentiates phenobarbital effects in the control of pentylenetetrazole (PTZ)-induced epileptic seizures in neonate rats.

Frontiers in pediatrics, 13, 1673345

Citation

Pinto, Lillian Soares; de Oliveira, Matheus Silva; Borges, Giovanna Bruno; de Castro, Olagide Wagner; Moreira, Fabrício de Araújo; Santos, Victor Rodrigues. (2025). Cannabidiol potentiates phenobarbital effects in the control of pentylenetetrazole (PTZ)-induced epileptic seizures in neonate rats.. Frontiers in pediatrics, 13, 1673345. https://doi.org/10.3389/fped.2025.1673345

Explore the wider topic